Drug Effective for Metastatic Triple Negative Breast Cancer
NYU Langone study finds pembrolizumab is effective in shrinking tumors among metastatic triple negative breast cancer patients.
Many Pelvic Tumors in Women Start in Fallopian Tubes
NYU Langone researchers find evidence that most ovarian cancers start in the fallopian tubes to which they are attached.
Men with Low-Risk Prostate Cancer May Avoid Surgery
NYU Langone study finds that more men with low-risk prostate cancer could opt out of immediate treatment.
New Science Building Lays the Groundwork for Collaboration
NYU Langone’s new 16-floor Science Building facilitates “cross talk” among researchers and disciplines.
NYU Langone Health in the News—July 24, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 24, 2024.
NYU Langone Hospital—Suffolk Joins Our Elite Health System
Long Island Community Hospital is now NYU Langone Hospital—Suffolk, a full-service inpatient facility serving residents in and around Patchogue, New York.
Renowned Orthopedic Surgeon to Lead Foot & Ankle Division
Renowned orthopedic surgery pioneer Dr. John G. Kennedy to lead NYU Langone’s Foot and Ankle Division.
Scientists Unravel How Exercise Benefits the Brain
NYU Langone study shows how exercise benefits a mammal’s brain and suggests new strategies to ward off neurological disease.
A Pioneering Transplant Surgeon Becomes a Transplant Patient
Pioneering transplant surgeon Dr. Robert Montgomery, director of NYU Langone’s Transplant Institute, becomes a pioneering transplant patient.
Antiphospholipid Syndrome Resolved for Patient with Lupus
Experts at NYU Langone resolve catastrophic antiphospholipid syndrome in highly complex patient with lupus and genetic abnormalities.